Canton Strategic Holdings (CNTN) Other Working Capital Changes (2021 - 2026)
Canton Strategic Holdings (CNTN) reported Other Working Capital Changes of $1.2 million for Q1 2026, up 183.57% on a YoY basis from $423103.0 in Q1 2025, and up 353.99% quarter-over-quarter from $264280.0 in Q4 2025.
Canton Strategic Holdings (CNTN) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Other Working Capital Changes for 6 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 183.57% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 12876.96% YoY), and the FY2025 full-year result was $308055.0, up 800.17% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $1.2 million, up from $264280.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.6 million in Q2 2022, with the low at -$898619.0 in Q1 2022.
- Historically, Other Working Capital Changes has averaged $87202.4 across 5 years, with a median of -$158387.0 in 2024.
- The largest YoY upside for Other Working Capital Changes was 3023.84% in 2022 against a maximum downside of 30833.0% in 2022.
- Canton Strategic Holdings' Other Working Capital Changes stood at -$243496.0 in 2022, then fell by 23.96% to -$301849.0 in 2023, then dropped by 4.27% to -$314746.0 in 2024, then jumped by 183.97% to $264280.0 in 2025, then jumped by 353.99% to $1.2 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.2 million (Q1 2026), $264280.0 (Q4 2025), and -$106980.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 264,280.00 |
| Dec 31, 2025 | 264,280.00 |
| Sep 30, 2025 | -106,980.00 |
| Sep 30, 2025 | -106,980.00 |
| Jun 30, 2025 | -272,348.00 |
| Jun 30, 2025 | -272,348.00 |
| Mar 31, 2025 | 423,103.00 |
| Mar 31, 2025 | 423,103.00 |
| Dec 31, 2024 | -314,746.00 |
| Dec 31, 2024 | -314,746.00 |
| Sep 30, 2024 | 58,389.00 |
| Sep 30, 2024 | 58,389.00 |
| Jun 30, 2024 | -158,387.00 |
| Jun 30, 2024 | -158,387.00 |
| Mar 31, 2024 | 448,966.00 |
| Mar 31, 2024 | 448,966.00 |
| Dec 31, 2023 | -301,849.00 |
| Dec 31, 2023 | -301,849.00 |